Michael F. Good - Concepedia

Author

Michael F. Good

QIMR Berghofer Medical Research Institute ORCID

Also Known As

Berkeley California, Good, Michael, Good, Michael F, M F Good, M Good, M. F. GOOD, M. F. Good, M.F Good, M.F. GOOD, M.F. Good

444

Publications

16.8K

Citations

H-Index

128

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute Griffith University The University of Queensland National Institute of Allergy and Infectious Diseases National Institutes of Health

About

Michael F. Good is an author at QIMR Berghofer Medical Research Institute specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	120	7.3K
2	Allergy	20	25	1.3K
3	Engineering	10	10	637
4	Public Health	4	4	144
5	Natural Sciences	3	3	103

Michael F. Good

237

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Walter R. Weiss, M Sedegah, Richard L. Beaudoin, Proceedings of the National Academy of Sciences Malaria SporozoitesVaccine DevelopmentT CellsMalariaImmunology	1988	486
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum D Pombo, Gregor Lawrence, Chakrit Hirunpetcharat, The Lancet Ultra-low DosesMalariaImmunologyRed CellsVector-parasite Relationship	2002	403
Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite Protein Michael F. Good, W. Lee Maloy, Milford N. Lunde, Science MalariaImmunologyMalaria Circumsporozoite ProteinImmunodominanceMolecular Biology	1987	271
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Michael F. Good, D Pombo, Isabella A. Quakyi, Proceedings of the National Academy of Sciences Laboratory ImmunologyMalariaImmunologyImmunodominanceAntigen Processing	1988	263
Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. Walter R. Weiss, S Mellouk, Richard A. Houghten, The Journal of Experimental Medicine Cytotoxic T CellsMalariaImmunologyImmune RegulationImmunodominance	1990	207
The 230-kDa gamete surface protein of <i>Plasmodium falciparum</i> is also a target for transmission-blocking antibodies. Isabella A. Quakyi, R Carter, J Rener, The Journal of Immunology	1987	197
Protection against Group A Streptococcus by Immunization with J8–Diphtheria Toxoid: Contribution of J8‐ and Diphtheria Toxoid–Specific Antibodies to Protection Michael R. Batzloff, Wendy A. Hayman, Mark R. Davies, The Journal of Infectious Diseases	2003	192
Research Toward Malaria Vaccines Louis H. Miller, Russell J. Howard, Richard Carter, Science VaccinationVaccinologyCause MalariaVaccine DevelopmentComplete Protection	1986	183
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. Michael F. Good, Jay A. Berzofsky, W L Maloy, The Journal of Experimental Medicine MalariaImmunologyImmunodominanceAntigen ProcessingImmunotherapy	1986	180
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum Sanjai Kumar, Louis H. Miller, Isabella A. Quakyi, Nature Plasmodium FalciparumCytotoxic T CellsParasitic ProtozoaPathogenesisImmunology	1988	179

Page 1